SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-021313
Filing Date
2020-05-05
Accepted
2020-05-05 16:43:57
Documents
44
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q atrs-10q_20200331.htm   iXBRL 10-Q 1298539
2 EX-31.1 atrs-ex311_6.htm EX-31.1 15726
3 EX-31.2 atrs-ex312_9.htm EX-31.2 15759
4 EX-32.1 atrs-ex321_7.htm EX-32.1 6462
5 EX-32.2 atrs-ex322_8.htm EX-32.2 6473
  Complete submission text file 0001564590-20-021313.txt   4354083

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA atrs-20200331.xsd EX-101.SCH 27284
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atrs-20200331_cal.xml EX-101.CAL 33524
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atrs-20200331_def.xml EX-101.DEF 81439
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE atrs-20200331_lab.xml EX-101.LAB 247240
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atrs-20200331_pre.xml EX-101.PRE 181677
38 EXTRACTED XBRL INSTANCE DOCUMENT atrs-10q_20200331_htm.xml XML 753863
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32302 | Film No.: 20849608
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences